Abstract
Purpose
The purpose of this review is to discuss current ideas on the definition, pathophysiology, diagnosis, and management of low-tension glaucoma (LTG).
Recent Findings
While previously considered a distinct entity, LTG may be a continuation of primary open angle glaucoma with intraocular pressures (IOPs) within the statistical range of “normal”. Vascular dynamics, sleep apnea, and intracranial pressure may play a role in patients with LTG.
Summary
LTG remains a diagnosis of exclusion. A thorough medical history and possible blood work-up and neuroimaging may help exclude nutritional deficiencies, toxicities, and intracranial masses. Vasculature dysregulation may play a role in LTG and account for its association with certain systemic conditions. IOP lowering remains the mainstay treatment of LTG, with caution advised for topical beta-blocker medications. Non-IOP-lowering therapy, such as treating underlying systemic conditions potentially affecting ocular blood flow (e.g. hypotension, anemia, sleep apnea) and nutritional supplements (Ginkgo biloba and resveratrol), may be beneficial and are currently being studied.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •Of importance ••Of major importance
American Academy of Ophthalmology, editor. Glaucoma. 2012th–3rd ed. San Francisco, Calif; 2012. 254 p. (Basic and clinical science course).
Kingman S. Glaucoma is second leading cause of blindness globally. Bull World Health Organ. 2004;82(11):887–8.
Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–90.
Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore eye survey. Arch Ophthalmol Chic Ill 1960. 1991;109(8):1090–5.
Dielemans I, Vingerling JR, Wolfs RC, Hofman A, Grobbee DE, de Jong PT. The prevalence of primary open-angle glaucoma in a population-based study in the Netherlands. The Rotterdam study. Ophthalmology. 1994;101(11):1851–5.
Varma R, Ying-Lai M, Francis BA, Nguyen BB-T, Deneen J, Wilson MR, et al. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2004;111(8):1439–48.
Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology. 2004;111(9):1641–8.
Fechtner RD, Weinreb RN. Mechanisms of optic nerve damage in primary open angle glaucoma. Surv Ophthalmol. 1994;39(1):23–42.
Yan DB, Coloma FM, Metheetrairut A, Trope GE, Heathcote JG, Ethier CR. Deformation of the lamina cribrosa by elevated intraocular pressure. Br J Ophthalmol. 1994;78(8):643–8.
Flammer J. The vascular concept of glaucoma. Surv Ophthalmol. 1994;38(Suppl):S3–6.
Flammer J, Mozaffarieh M. What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv Ophthalmol. 2007;52(Suppl 2):S162–73.
Flammer J, Haefliger IO, Orgül S, Resink T. Vascular dysregulation: a principal risk factor for glaucomatous damage? J Glaucoma. 1999;8(3):212–9.
Flammer J, Orgül S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21(4):359–93.
Pache M, Dubler B, Flammer J. Peripheral vasospasm and nocturnal blood pressure dipping—two distinct risk factors for glaucomatous damage? Eur J Ophthalmol. 2003;13(3):260–5.
Kaiser HJ, Flammer J. Systemic hypotension: a risk factor for glaucomatous damage? Ophthalmol J Int Ophtalmol Int J Ophthalmol Z Für Augenheilkd. 1991;203(3):105–8.
Kaiser HJ, Flammer J, Graf T, Stümpfig D. Systemic blood pressure in glaucoma patients. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Für Klin Exp Ophthalmol. 1993;231(12):677–80.
Orgül S, Kaiser HJ, Flammer J, Gasser P. Systemic blood pressure and capillary blood-cell velocity in glaucoma patients: a preliminary study. Eur J Ophthalmol. 1995;5(2):88–91.
• Mroczkowska S, Benavente-Perez A, Negi A, Sung V, Patel SR, Gherghel D. Primary open-angle glaucoma vs normal-tension glaucoma: the vascular perspective. JAMA Ophthalmol. 2013;131(1):36–43. This study compares ocular and systemic vascular regulation in patients with POAG and LTG. Results suggest that vascular risk factors are similar between the two groups, suggesting that they are on the same disease spectrum
Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res. 2001;20(3):319–49.
Wu X, Liu H. Obstructive sleep apnea/hypopnea syndrome increases glaucoma risk: evidence from a meta-analysis. Int J Clin Exp Med. 2015;8(1):297–303.
Bilgin G. Normal-tension glaucoma and obstructive sleep apnea syndrome: a prospective study. BMC Ophthalmol. 2014;14:27.
Kiekens S, Veva De Groot, Coeckelbergh T, Tassignon M-J, van de Heyning P, Wilfried De Backer, et al. Continuous positive airway pressure therapy is associated with an increase in intraocular pressure in obstructive sleep apnea. Invest Ophthalmol Vis Sci. 2008;49(3):934–40.
Berdahl JP, Fautsch MP, Stinnett SS, Allingham RR. Intracranial pressure in primary open angle glaucoma, normal tension glaucoma, and ocular hypertension: a case-control study. Invest Ophthalmol Vis Sci. 2008;49(12):5412–8.
Morgan WH, Yu DY, Cooper RL, Alder VA, Cringle SJ, Constable IJ. The influence of cerebrospinal fluid pressure on the lamina cribrosa tissue pressure gradient. Invest Ophthalmol Vis Sci. 1995;36(6):1163–72.
Palamar M, Dag MY, Yagci A. The effects of valsalva manoeuvre on ocular response analyzer measurements. Clin Exp Optom. 2015;98(5):447–50.
Teng C, Gurses-Ozden R, Liebmann JM, Tello C, Ritch R. Effect of a tight necktie on intraocular pressure. Br J Ophthalmol. 2003;87(8):946–8.
Kim KN, Jeoung JW, Park KH, Kim DM, Ritch R. Relationship between preferred sleeping position and asymmetric visual field loss in open-angle glaucoma patients. Am J Ophthalmol. 2014;157(3):739–45.
Carrim ZI, Lavy TE. Goldmann tonometry versus the Tono-Pen XL for intraocular pressure measurement: an evaluation of the potential impact on clinical decision making in glaucoma. Ophthalmic Physiol Opt J Br Coll Ophthalmic Opt Optom. 2009;29(6):648–51.
Molina N, Milla E, Bitrian E, Larena C, Martínez L. Comparison of Goldmann tonometry, pneumotonometry and the effect of the central corneal thickness. Arch Soc Esp Oftalmol. 2010;85(10):325–8.
Mehdizadeh A, Hoseinzadeh A, Fazelzadeh A. Central corneal thickness as a risk factor for glaucoma. Med Hypotheses. 2007;69(6):1205–7.
Ishida K, Yamamoto T, Sugiyama K, Kitazawa Y. Disk hemorrhage is a significantly negative prognostic factor in normal-tension glaucoma. Am J Ophthalmol. 2000;129(6):707–14.
Javitt JC, Spaeth GL, Katz LJ, Poryzees E, Addiego R. Acquired pits of the optic nerve. Increased prevalence in patients with low-tension glaucoma. Ophthalmology. 1990;97(8):1038–43. discussion 1043–4
Park SC, De Moraes CG, Teng CCW, Tello C, Liebmann JM, Ritch R. Initial parafoveal versus peripheral scotomas in glaucoma: risk factors and visual field characteristics. Ophthalmology. 2011;118(9):1782–9.
Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998; 126(4):487–97.
Vianna JR, Chauhan BC. How to detect progression in glaucoma. Prog Brain Res. 2015;221:135–58.
Hangai M, Ikeda HO, Akagi T, Yoshimura N. Paracentral scotoma in glaucoma detected by 10-2 but not by 24-2 perimetry. Jpn J Ophthalmol. 2014;58(2):188–96.
Blumberg D, Skaat A, Liebmann JM. Emerging risk factors for glaucoma onset and progression. Prog Brain Res. 2015;221:81–101.
de Beaufort HC, De Moraes CGV, Teng CC, Prata TS, Tello C, Ritch R, et al. Recurrent disc hemorrhage does not increase the rate of visual field progression. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Für Klin Exp Ophthalmol. 2010;248(6):839–44.
Marquis RE, Whitson JT. Management of glaucoma: focus on pharmacological therapy. Drugs Aging. 2005;22(1):1–21.
Soltau JB, Zimmerman TJ. Changing paradigms in the medical treatment of glaucoma. Surv Ophthalmol. 2002;47(Suppl 1):S2–5.
•• Krupin T, Liebmann JM, Greenfield DS, Ritch R, Gardiner S. Low-pressure glaucoma study group. A randomized trial of brimonidine versus timolol in preserving visual function: results from the low-pressure glaucoma treatment study. Am J Ophthalmol. 2011;151(4):671–81. This study is a randomized multicenter clinical trial that showed that brimonidine may exert some protective effects compared to timolol in low tension glaucoma patients. Results might have been skewed by a high drop out rate in the brimonidine group
Garudadri CS, Choudhari NS, Rao HL, Senthil S. A randomized trial of brimonidine versus timolol in preserving visual function: results from the low-pressure glaucoma treatment study. Am J Ophthalmol. 2011;152(5):877. author reply 877–8
Liu CJ, Cheng C-Y, Ko Y-C, Hsu W-M. Diurnal intraocular pressure and blood pressure with two dosing regimens of brimonidine in normal tension glaucoma. J Chin Med Assoc JCMA. 2004;67(9):465–71.
Wong MOM, Lee JWY, Choy BNK, Chan JCH, Lai JSM. Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma. Surv Ophthalmol. 2015;60(1):36–50.
European Glaucoma Society, editor. Terminology and guidelines for glaucoma. 4th ed. Savona: PubliComm; 2014. 195 p.
Lee JWY, Shum JJW, Chan JCH, Lai JSM. Two-year clinical results after selective laser trabeculoplasty for normal tension glaucoma. Medicine (Baltimore). 2015;94(24):e984.
Lee JWY, Liu CCL, Chan JCH, Lai JSM. Predictors of success in selective laser trabeculoplasty for normal tension glaucoma. Medicine (Baltimore). 2014;93(28):e236.
Tojo N, Oka M, Miyakoshi A, Ozaki H, Hayashi A. Comparison of fluctuations of intraocular pressure before and after selective laser trabeculoplasty in normal-tension glaucoma patients. J Glaucoma. 2014;23(8):e138–43.
Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL, et al. Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012; 153(5):789–803.e2.
• Song BJ, Caprioli J. New directions in the treatment of normal tension glaucoma. Indian J Ophthalmol. 2014;62(5):529–37. This article discusses new possible therapies for the treatment of low tension glaucoma. Medications used in other conditions and nutritional supplements sound promising for the treatment of low tension glaucoma
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Anjali Bhorade reports grants from the National Eye Institute outside the submitted work. Anitra Turner declares no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Diagnosis and Monitoring of Glaucoma
Rights and permissions
About this article
Cite this article
Turner, A., Bhorade, A. Diagnosis and Monitoring of Low-Tension Glaucoma. Curr Ophthalmol Rep 5, 1–6 (2017). https://doi.org/10.1007/s40135-017-0117-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40135-017-0117-4